Sign in or Register
  |  

Creative Biolabs has successfully developed SARS, MERS and other anti-viral antibodies in the past to assist scientific research. Facing the difficult COVID-19, Creative Biolabs actively invests in antibody development to assist researchers to better understand the characteristics of 2019-nCoV and drug development. Currently, Creative Biolabs is proud to offer an extensive line of research antibodies to support the study of SARS-CoV-2/COVID-19, several of which were validated using virus-infected cell lysates.

Explore the collections of SARS-CoV-2/COVID-19 antibodies >

Cardiac & Cholesterol Markers

Creative Biolabs offers the most comprehensive list of recombinant antibody products used in the diagnostics of cardiac & cholesterol.

Cardiovascular diseases are increasing day by day due to over utilization of fats or due to genetic reasons. It is a leading cause of morbidity and mortality from infancy to old age. Therefore, an early identification and treatment of risk factors are much needed to accelerate disease prevention and morbidity improvement. Up to now, a number of physiological biomarkers based on serum lipid, glucose and hormone profile have been identified. They are associated with increased cardiovascular risk. Moreover, a variety of cardiovascular risk prediction models have been established and updated by incorporating traditional risk factors and molecular, immunological genetic, imaging, and biophysical factors for more authentic and reliable estimation or cardiovascular risk.